Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent six days a week. By signing up, you confirm you are 16+, will receive newsletters and promotional content and agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. The United Service
Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent six days a week. By signing up, you confirm you are 16+, will receive newsletters and promotional content and agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. The current digital
Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent six days a week. By signing up, you confirm you are 16+, will receive newsletters and promotional content and agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. What’s the weirdest
That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer “personalised mRNA cancer vaccines for dogs.” But his ambitions go well beyond dogs — and pets — with Gamgee’s website promising the company will harness AI and genetics to develop personalized treatments for a range of diseases and species, including humans. At
In addition to the S52A designation, one of the submitted documents shows an oval diagram — likely the ear cup — marked with the name Sonos Ace Ultra, although that name isn’t listed anywhere else. It follows the naming scheme Sonos has used in the past with its Arc and Arc Ultra soundbars. The documents
After a former lead writer claimed Saber “replaced me with ChatGPT,” CEO Matthew Karch now claims, “Neither Saber nor Unigine have replaced any writers with AI,” for the Rideshare “Stimulator” game announced last month, developed by Unigine. The writer, Stella Sacco, says differently, however, posting on Bluesky that “I was lead writer on this one!